SLC6A3
SLC6A3 is the sodium-dependent dopamine transporter, also known as DAT or DAT1. It mediates sodium- and chloride-dependent transport of dopamine and belongs to the SLC6 family of neurotransmitter transporters. Browse Assay Genie's current range of SLC6A3 research reagents below, or read on for the biology behind the target.
SLC6A3 mediates sodium- and chloride-dependent transport of dopamine across the cell membrane. It also mediates sodium- and chloride-dependent transport of norepinephrine, also known as noradrenaline. UniProt additionally describes a role as a regulator of light-dependent retinal hyaloid vessel regression, downstream of OPN5 signalling.
The protein, named sodium-dependent dopamine transporter in UniProt, belongs to the sodium:neurotransmitter symporter (SNF) family, TC 2.A.22, and to the SLC6A3 subfamily. In HGNC it sits within the solute carrier family 6 gene group. It localises to the cell membrane, including neuron projections and axons. The mouse and rat orthologues are both named Slc6a3, which is relevant when selecting a SLC6A3 antibody or other reagent for work in rodent models.
The SLC6A3 gene was previously described as solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, and as dopamine transporter 1; the symbols DAT and DAT1 are still in common use. According to the NCBI Gene summary, the 3' UTR of the gene contains a 40 bp variable number tandem repeat (VNTR) present in 3 to 11 copies. Variation in repeat number is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.
SLC6A3 transports dopamine across the cell membrane in a sodium- and chloride-dependent manner, making it a focus for studies of dopaminergic signalling.
VNTR variation in the SLC6A3 gene is associated with attention-deficit hyperactivity disorder and with dependence on alcohol and cocaine.
Variation at the SLC6A3 locus is linked to susceptibility to Parkinson disease, so the transporter is studied in dopaminergic pathology.
SLC6A3 regulates light-dependent regression of retinal hyaloid vessels downstream of OPN5 signalling, linking the transporter to eye development.
SLC6A3, the sodium-dependent dopamine transporter, mediates sodium- and chloride-dependent transport of dopamine and also of norepinephrine. UniProt further reports that it regulates light-dependent retinal hyaloid vessel regression downstream of OPN5 signalling.
The HGNC name is solute carrier family 6 member 3, and the common aliases are DAT and DAT1. Earlier names include dopamine transporter 1 and solute carrier family 6 (neurotransmitter transporter, dopamine), member 3. UniProt names the protein sodium-dependent dopamine transporter.
Mouse and rat both have a Slc6a3 orthologue. In humans, NCBI reports that VNTR copy number in the 3' UTR is associated with idiopathic epilepsy, ADHD, alcohol and cocaine dependence, and Parkinson disease susceptibility. Check the datasheet of any product for its validated reactivity.
Other solute carrier transporters, including neurotransmitter and monoamine transporters, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q01959; product specifications from Assay Genie datasheets.